Stryker Corporation $SYK Shares Purchased by Aberdeen Group plc

Key Points

• Aberdeen Group plc increased its stake in Stryker Corporation by 60.8%, acquiring an additional 125,703 shares during the 1st quarter, bringing its total shares to 332,286, valued at approximately $122.5 million.
• Several institutional investors, including Horizon Investments LLC and Vestmark Advisory Solutions Inc., also raised their holdings in Stryker during the same period, with hedge funds currently owning 77.09% of the stock.
• Stryker Corporation recently announced a quarterly dividend of $0.84 per share, scheduled for payment on October 31st, which corresponds to an annualized dividend yield of 0.9%.

Aberdeen Group plc lifted its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 60.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 332,286 shares of the medical technology company's stock after purchasing an additional 125,703 shares during the period. Aberdeen Group plc owned about 0.09% of Stryker worth $122,502,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of SYK. Capital A Wealth Management LLC purchased a new stake in Stryker during the 4th quarter valued at about $26,000. Goodman Advisory Group LLC purchased a new stake in Stryker during the 1st quarter valued at about $32,000. City Holding Co. grew its stake in Stryker by 528.6% during the 1st quarter. City Holding Co. now owns 88 shares of the medical technology company's stock valued at $33,000 after acquiring an additional 74 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Stryker in the 1st quarter valued at approximately $40,000. Finally, Itau Unibanco Holding S.A. purchased a new stake in shares of Stryker in the 4th quarter valued at approximately $42,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares of the company's stock, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 5.90% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SYK. Needham & Company LLC increased their price target on shares of Stryker from $442.00 to $448.00 and gave the company a "buy" rating in a research note on Friday, August 1st. JMP Securities reissued a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Wall Street Zen upgraded shares of Stryker from a "hold" rating to a "buy" rating in a report on Friday, July 18th. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a report on Monday, May 5th. Finally, Wells Fargo & Company upped their price objective on shares of Stryker from $435.00 to $445.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Fifteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $430.10.

Stryker Stock Up 2.2%

Shares of NYSE:SYK traded up $8.3540 during trading hours on Tuesday, reaching $389.9640. The stock had a trading volume of 1,655,063 shares, compared to its average volume of 1,434,516. Stryker Corporation has a 1 year low of $329.16 and a 1 year high of $406.19. The firm's 50 day moving average is $386.77 and its 200-day moving average is $379.38. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The stock has a market capitalization of $149.09 billion, a price-to-earnings ratio of 51.65, a P/E/G ratio of 2.78 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating analysts' consensus estimates of $3.07 by $0.06. The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Research analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker's dividend payout ratio (DPR) is presently 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.